HCPLive Network

Most Patients Are Unaware of Out-of-Pocket Costs for Prostate Cancer Treatment

 
FRIDAY, Jan. 4 (HealthDay News) -- Most patients with localized prostate cancer know little about the out-of-pocket expenses (OOPE) of the different treatments, and would not have chosen a different treatment even if they had known the actual OOPE of their treatment, according to a study published in the December issue of Urology.

Olivia S. Jung, from Harvard Business School in Boston, and colleagues conducted a qualitative research study involving 41 patients with clinically localized prostate cancer enrolled from the urology and radiology practices of the University of Pennsylvania. Participants completed a semi-structured interview and questionnaire discussing the burden of OOPE, its effect on treatment decisions, and prior knowledge of OOPE.

Based on qualitative assessment, the researchers identified five major themes: "my insurance takes care of it;" "health is more important than cost;" "I did not look into it;" "I cannot afford it but would have chosen the same treatment;" and "it is not my doctor's business." Ninety-three percent of patients reported that, even if they had known the actual OOPE of their treatment, they would not have chosen a different treatment. A socioeconomically heterogeneous group reported feeling burdened by OOPE, and their choice of treatment was unaffected. Before choosing their treatment, only two of the patients reported knowing a lot about the likely OOPE for different treatments.

"Among insured patients with prostate cancer treated at a large academic medical center, few had knowledge of OOPE before making treatment choices," the authors write.
 

Abstract
Full Text (subscription or payment may be required)

 
Copyright © 2013 HealthDay. All rights reserved.
 

Further Reading
Physician career transitioning is a growth industry. How do you get there? Start by writing a SOAP note.
Continuing the discussion of the dangers of energy drinks the topic turns to what parents and the drink manufacturers can do to protect the youngest members of the population.
A presentation at the American Heart Association (AHA) Scientific Sessions 2014 suggested, STEMI victims treated with oxygen endured 25 to 30% more heart damage than patients not given oxygen.
More Reading